UB Paderborn / Katalog / Suche / in CDI

Targeting the p300/CBP Axis in Lethal Prostate Cancer

Cancer discovery, 2021-05, Vol.11 (5), p.1118-1137

2021

Volltextzugriff (PDF)

Design and synthesis of a potent, highly selective, orally bioavailable, retinoic acid receptor alpha agonist

Bioorganic & medicinal chemistry, 2018-02, Vol.26 (4), p.798-814

2018

Volltextzugriff (PDF)

Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant Asthma

Journal of medicinal chemistry, 2016-03, Vol.59 (5), p.1727-1746

2016

Volltextzugriff (PDF)

An expedient approach to the 2,3,5,6-tetrasubstituted pyridine core of nosiheptide using oxidative cleavage of 2,3,5,8-tetrasubstituted quinolines

ARKIVOC, 2007-01, Vol.2007 (11), p.56-63

2007

Volltextzugriff (PDF)

Abstract 1575: Novel small molecule inhibitors of p300/CBP down-regulate AR and c-Myc for the treatment of castrate resistant prostate cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1575-1575

2017

Volltextzugriff (PDF)

Characterisation of CCS1477: A novel small molecule inhibitor of p300/CBP for the treatment of castration resistant prostate cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.11590-11590

2017

Volltextzugriff (PDF)

A novel small molecule inhibitor of p300/CBP for the treatment of castration-resistant prostate cancer: Preclinical evaluation

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.168-168

2017

Volltextzugriff (PDF)

Synthesis of the Reported Structure of the Bisbenzoquinone Lanciaquinone, Isolated from Maesa lanceolata

Organic letters, 2008-10, Vol.10 (20), p.4505-4508

2008

Volltextzugriff (PDF)

2-(Benzylsulfanyl)-6-chloro-9-isopropylpurine, a Valuable Intermediate in the Synthesis of Diaminopurine Cyclin Dependent Kinase Inhibitors

European Journal of Organic Chemistry, 2005-03, Vol.2005 (5), p.939-947

2005

Volltextzugriff (PDF)

Synthesis and full characterisation of 6-chloro-2-iodopurine, a template for the functionalisation of purines

Organic & biomolecular chemistry, 2004-03, Vol.2 (5), p.665-670

2004

Volltextzugriff (PDF)

ChemInform Abstract: Synthesis of the Reported Structure of the Bisbenzoquinone Lanciaquinone, Isolated from Maesa lanceolata

ChemInform, 2009-03, Vol.40 (11), p.no-no

2009

Volltextzugriff (PDF)

Incidence and Mortality of Acute‐on‐Chronic Liver Failure Using Two Definitions in Patients with Compensated Cirrhosis

Hepatology (Baltimore, Md.), 2019-05, Vol.69 (5), p.2150-2163

2019

Volltextzugriff (PDF)

Grade 1 Acute on Chronic Liver Failure Is a Predictor for Subsequent Grade 3 Failure

Hepatology (Baltimore, Md.), 2020-07, Vol.72 (1), p.230-239

2020

Volltextzugriff (PDF)

Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database

Clinical gastroenterology and hepatology, 2015-12, Vol.13 (13), p.2333-2341.e6

2015

Volltextzugriff (PDF)

The Association Between Proton Pump Inhibitor Exposure and Key Liver-Related Outcomes in Patients With Cirrhosis: A Veterans Affairs Cohort Study

Gastroenterology (New York, N.Y. 1943), 2022-07, Vol.163 (1), p.257-269.e6

2022

Volltextzugriff (PDF)

Risk prediction of late-onset Alzheimer's disease implies an oligogenic architecture

Nature communications, 2020-09, Vol.11 (1), p.4799-4799, Article 4799

2020

Volltextzugriff (PDF)

Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation

The New England journal of medicine, 2016-01, Vol.374 (4), p.344-353

2016

Volltextzugriff (PDF)

Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality

Gastroenterology (New York, N.Y. 1943), 2017-06, Vol.152 (8), p.1954-1964

2017

Volltextzugriff (PDF)

Rates of decompensation, hepatocellular carcinoma and mortality in AMA‐negative primary biliary cholangitis cirrhosis

Liver international, 2022-02, Vol.42 (2), p.384-393

2022

Volltextzugriff (PDF)

Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores

Gastroenterology (New York, N.Y. 1943), 2019-11, Vol.157 (5), p.1264-1278.e4

2019

Volltextzugriff (PDF)

A method for resolving organisation‐enterprise system misfits: An action research study in a pluralistic organisation

Information systems journal (Oxford, England), 2023-09, Vol.33 (5), p.995-1028

2023

Volltextzugriff (PDF)

Association of BNT162b2 mRNA and mRNA-1273 Vaccines With COVID-19 Infection and Hospitalization Among Patients With Cirrhosis

JAMA internal medicine, 2021-10, Vol.181 (10), p.1306

2021

Volltextzugriff (PDF)

Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study

Journal of clinical oncology, 2017-11, Vol.35 (31), p.3575-3581

2017

Volltextzugriff (PDF)

Patterns of Care Utilization and Hepatocellular Carcinoma Surveillance: Tracking Care Across the Pandemic

The American journal of gastroenterology, 2023-02, Vol.118 (2), p.294-303

2023

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Targeting the p300/CBP Axis in Lethal Prostate Cancer

Design and synthesis of a potent, highly selective, orally bioavailable, retinoic acid receptor alpha agonist

Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant Asthma

An expedient approach to the 2,3,5,6-tetrasubstituted pyridine core of nosiheptide using oxidative cleavage of 2,3,5,8-tetrasubstituted quinolines

Abstract 1575: Novel small molecule inhibitors of p300/CBP down-regulate AR and c-Myc for the treatment of castrate resistant prostate cancer

Characterisation of CCS1477: A novel small molecule inhibitor of p300/CBP for the treatment of castration resistant prostate cancer

A novel small molecule inhibitor of p300/CBP for the treatment of castration-resistant prostate cancer: Preclinical evaluation

Targeting p300/CBP in lethal prostate cancer

Synthesis of the Reported Structure of the Bisbenzoquinone Lanciaquinone, Isolated from Maesa lanceolata

2-(Benzylsulfanyl)-6-chloro-9-isopropylpurine, a Valuable Intermediate in the Synthesis of Diaminopurine Cyclin Dependent Kinase Inhibitors

Synthesis and full characterisation of 6-chloro-2-iodopurine, a template for the functionalisation of purines

ChemInform Abstract: Synthesis of the Reported Structure of the Bisbenzoquinone Lanciaquinone, Isolated from Maesa lanceolata

Incidence and Mortality of Acute‐on‐Chronic Liver Failure Using Two Definitions in Patients with Compensated Cirrhosis

Grade 1 Acute on Chronic Liver Failure Is a Predictor for Subsequent Grade 3 Failure

Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database

The Association Between Proton Pump Inhibitor Exposure and Key Liver-Related Outcomes in Patients With Cirrhosis: A Veterans Affairs Cohort Study

Risk prediction of late-onset Alzheimer's disease implies an oligogenic architecture

Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation

Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality

Rates of decompensation, hepatocellular carcinoma and mortality in AMA‐negative primary biliary cholangitis cirrhosis

Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores

A method for resolving organisation‐enterprise system misfits: An action research study in a pluralistic organisation

Association of BNT162b2 mRNA and mRNA-1273 Vaccines With COVID-19 Infection and Hospitalization Among Patients With Cirrhosis

Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study

Patterns of Care Utilization and Hepatocellular Carcinoma Surveillance: Tracking Care Across the Pandemic

Aktive Filter

Suchergebnisse filtern